CE15 - Immunologie, Infectiologie et Inflammation 2021

Immunosuppressive function of NFATc1 in the intestinal tuft cell-immune crosstalk controlling helminth infection – TUFTREG

Submission summary

The intestinal epithelium, constituted of a single cell layer, represents the only border with the hostile environment in the gut lumen, containing foreign organisms and other toxic compounds. Maintenance of homeostasis requires crosstalk between the epithelium and the immune system, both at the steady state and during immune responses. We recently discovered the function of intestinal tuft cells in the initiation of type 2 immune responses following infection with helminth parasites. This tuft cell-mediated response is critical as worm expulsion is compromised in mice which are lacking tuft cells. However, most natural parasites have co-evolved with their hosts to develop strategies that dampen host immunity, thereby improving their survival. In this project, we will explore a novel regulatory circuit in tuft cells that is targeted by helminth parasites to inhibit type 2 immune responses. This study, using both in vivo and ex vivo models, will allow us to decipher the pathways via which helminths avert immune rejection. The identification of these mechanisms may be exploited to develop innovative therapies for patients with type2-induced diseases, including allergies and chronic inflammatory bowel diseases.

Project coordination

Philippe JAY (Institut de génomique fonctionnelle)

The author of this summary is the project coordinator, who is responsible for the content of this summary. The ANR declines any responsibility as for its contents.

Partnership

IGF Institut de génomique fonctionnelle
IGMM Institut de génétique moléculaire de Montpellier

Help of the ANR 600,825 euros
Beginning and duration of the scientific project: December 2021 - 36 Months

Useful links

Explorez notre base de projets financés

 

 

ANR makes available its datasets on funded projects, click here to find more.

Sign up for the latest news:
Subscribe to our newsletter